![Jon Amund Eriksen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jon Amund Eriksen was the founder of Hubro Therapeutics AS, founded in 2018, serving as Managing Director.
Former job includes Chief Operating Officer at Circio Holding ASA from 2011 to 2017.
Education includes a graduate degree from the University of Oslo.
Anciens postes connus de Jon Amund Eriksen
| Sociétés | Poste | Fin |
|---|---|---|
| CIRCIO HOLDING ASA | Directeur des opérations | 31/12/2017 |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Directeur Général | - |
Formation de Jon Amund Eriksen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Health Technology |
